Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Moses

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
Diabetes|January 1, 1996
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetesA C Moses, S C Young, L A Morrow, et al.
Nutritional Neuroscience|July 14, 2016
Impaired Response of Serum IGF-I Levels to Puberty in Previously Malnourished AdolescentsJ R Galler, F C Ramsey, S J Pilistine, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1977
Identification of a receptor for somatomedin-like polypeptides in human fibroblastsM M Rechler, S P Nissley, J M Podskalny, et al.
Diabetes Research and Clinical Practice|August 1, 1995
Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitusA C Moses, L A Morrow, M O'Brien, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1984
Specific insulin binding sites in human ovaryL Poretsky, D Smith, M Seibel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1989
Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretionD E Moller, A C Moses, K Jones, et al.
Endocrinology|September 1, 1989
Differentiation-dependent phosphorylation of a 175,000 molecular weight protein in response to insulin and insulin-like growth factor-I in L6 skeletal muscle cellsF Beguinot, C R Kahn, A C Moses, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistanceL A Morrow, M B O'Brien, D E Moller, et al.
European Journal of Biochemistry|January 1, 1980
Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-liver-cell-conditioned mediumA C Moses, S P Nissley, P A Short, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Short-term hyperthyroidism has no effect on leptin levels in manC S Mantzoros, H N Rosen, S L Greenspan, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Diabetes|January 1, 1996
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetesA C Moses, S C Young, L A Morrow, et al.
Nutritional Neuroscience|July 14, 2016
Impaired Response of Serum IGF-I Levels to Puberty in Previously Malnourished AdolescentsJ R Galler, F C Ramsey, S J Pilistine, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1977
Identification of a receptor for somatomedin-like polypeptides in human fibroblastsM M Rechler, S P Nissley, J M Podskalny, et al.
Diabetes Research and Clinical Practice|August 1, 1995
Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitusA C Moses, L A Morrow, M O'Brien, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1984
Specific insulin binding sites in human ovaryL Poretsky, D Smith, M Seibel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1989
Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretionD E Moller, A C Moses, K Jones, et al.
Endocrinology|September 1, 1989
Differentiation-dependent phosphorylation of a 175,000 molecular weight protein in response to insulin and insulin-like growth factor-I in L6 skeletal muscle cellsF Beguinot, C R Kahn, A C Moses, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistanceL A Morrow, M B O'Brien, D E Moller, et al.
European Journal of Biochemistry|January 1, 1980
Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-liver-cell-conditioned mediumA C Moses, S P Nissley, P A Short, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Short-term hyperthyroidism has no effect on leptin levels in manC S Mantzoros, H N Rosen, S L Greenspan, et al.
Pageof 21